Letter/Comment
The latest advocacy letters and comments from the American Hospital Association.
January 27, 2025Jeff WuActing AdministratorCenters for Medicare & Medicaid Services7500 Security BlvdBaltimore, MD 21244Re: CMS 4208-P, Medicare and Medicaid Programs; Contract Year 2026 Policy and Technical Changes to the Medicare Advantage Program, Medicare Prescription Drug Benefit Program,…
A follow-up to Baxter’s communication on December 13, 2024 regarding increases in allocations for several U.S. IV products,
AHA Comments in advance of MedPAC January 2025 meeting.
AHA shares feedback in response to the Centers for Medicare & Medicaid Services’ information collection request (ICR) regarding the Medicare Transaction Facilitator (MTF) and the Medicare drug negotiation program.
AHA comments regarding the Centers for Medicare & Medicaid Services Medicare $2 Drug List (M2DL) Model request for information (RFI).
AHA comments regarding the Medicare Payment Advisory Commission (MedPAC) November meeting sessions related to physician fee schedule payments, advanced alternative payment model (A-APM) incentives and Medicare Advantage (MA) network adequacy.
The AHA has long stated that while we appreciated CMS’ recognition of the wage index’s shortcomings, the agency should not have implemented this policy by penalizing all hospitals, especially when Medicare already pays far less than the cost of providing care. As such, if CMS does address payments…
AHA, others urge congress to extend Medicare advanced alternative payment model in end-of-year legislative package.
AHA respond to Reps. Paul Tonko and Mike Turner's questions about how hospitals and health systems across the country are working to expand access to addiction treatment and what additional steps Congress can take to eliminate the remaining barriers.
AHA letter urging Congress to act on key priorities in Lame-duck session.